Association between AT C573T polymorphism and cardiovascular risk factors in myocardial infarction

Cardiovascular Pathology

Volumn 20, Issue 3, 2011, Pages 156-161

  Morales Suarez Varela, Maria M ^a,b,c   Riera Fortuny, Concepción ^d   Mansego, Maria Luisa ^a,e   Martinez Triguero, Maria Luisa ^f   Chaves, Felipe Javier ^a,g   Martin Moreno, Jose M ^a,h   Bañuls, Celia ^b,c   Hernandez Mijares, Antonio ^b,c,i  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Xirivella Health Centre   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

ⁱ UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Angiotensin II receptor gene; Ischemic heart disease; Polymorphisms of the renin angiotensin system; Prevention factors

Indexed keywords

ANGIOTENSIN RECEPTOR; APOLIPOPROTEIN A1; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SKINFOLD THICKNESS; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN;

EID: 79955694750     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2010.04.002     Document Type: Article

References (29)

1. Hernández-Mijares A, Riera-Fortuny C, Solà-Izquierdo E, Oliver Oliver MJ, Martínez-Triguero ML, Morillas Ariño C, Morales-Suárez- Varela M. Prevalence of metabolic syndrome in patients with coronary heart disease. Med Clin 2003;121(6):204-8. (Pubitemid 36974785)
2. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wilman B, de Faire U, Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007;298:1300-11. (Pubitemid 47443344)
3. Domingues-Montanari S, Subirana I, Tomás M, Marrugat J, Sentí M. Association between ESR2 genetic variants and risk of myocardial infarction. Clin Chem 2008;54(7):1183-9. (Pubitemid 352009695)
4. Halder I, Muldoon MF, Ferrell RE, Manuck SB. Serotonin receptor 2A (HTR2A) gene polymorphisms are associated with blood pressure, central adiposity, and the metabolic syndrome. Metab Syndr Relat Disord 2007;5(4):323-30. (Pubitemid 350208896)
5. Järemo P, Nilsson O. Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction. Eur J Intern Med 2008;19(5):330-3.
6. Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL. Plasma N-terminal B-type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional proatrial natriuretic peptide: the LAMP. J Am Coll Cardiol 2008;51(19):1857-64. (Pubitemid 351615250)
7. Chaves FJ, Pascual JM, Rovira E, Armengod ME, Redon J. Angiotensin II AT1 receptor gene polymorphism and microalbuminuria in essential hypertension. Am J Hypertens 2001;14:364-70.
8. Tiago AD, Bandenhorst D, Nkeh B, Candy GP, Brooksbank R, Sareli P, Libhaber E, Samani NJ, Woodiwiss AJ, Norton GR. Impact of renin-angiotensin- aldosterone system gene variants on the severity of hypertension in patients with newly diagnosed hypertension. Am J Med Sci 2004;328(5):266-73.
9. Galderisi M, Divitiis OD. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 2008;51(6):523-31.
10. Strazzullo P, Iacone R, Iacovello L, Russo O, Barba G, Russo P, D'Orazio A, Barbato A, Cappuccio FP, Farinaro E, Siani A. Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Intern Med 2003;138(1):17-23. (Pubitemid 36232090)
11. Riera-Fortuny C, Real JT, Chaves FJ, Morales-Suarez-Varela M, Martínez-Triguero ML, Morillas Ariño C, Hernández-Mijares A. The relation between obesity, abdominal fat deposit and the angiotensin-converting enzyme gene I/D polymorphism and its association with coronary heart disease. Int J Obes (Lond) 2005;29(1):78-84. (Pubitemid 40065468)
12. Staessen J, Wang JG, Ginocchio G, Petrov V, Saavedra A, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and the cardiovascular-renal risk. J Hypertens 1997;15:1379-592.
13. Su S, Chen J, Zhao J, Huang J, Wang X, Chen R, Gu D. Angiotensin II type 1 receptor gene and myocardial infarction: tagging SNPs and haplotype based association study: the Beijing Atherosclerosis Study. Pharmacogenetics 2004;14:673-81. (Pubitemid 39411267)
14. Araujo MA, Goulart LR, Codeiro ER, Gatti RR, Menezes BS, Lourenço C, Silva HD. Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int J Cardiol 2005;103:27-32. (Pubitemid 41074600)
15. Rodríguez-Pérez JC, Rodríguez-Esparragón F, Hernández-Perera O, Anabitarte A, Losada A, Medina A, Hernández E, Fiuza D, Avalos O, Yunis C, Ferrario CM. Association of angiotensinogen M235T and A(-6) G gene polymorphism with coronary heart disease with independence of essential hypertension: the PROCAGENE study (Prospective Cardiac Gene). J Am Coll Cardiol 2001;37(6):1536-42.
16. Andrikopoulos GK, Tzeis SM, Neddham EW, Richter DJ, Zairis MN, Gialafos EJ, Kardaras FG, Foussas SG, Stefanadis CI, Toutouzas PK, Mattu R, GEMIG Study Investigators. Lack of association between common polymorphisms in genes of the renin-angiotensin system and mortality after myocardial infarction. Cardiology 2005;103:185-8. (Pubitemid 40875049)
17. Franco E, Palumbo L, Crobu F, Anselmino M, Frea S, Matullo G, Piazza A, Trevi GP, Bergerone S. Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet 2007;8:27.
18. Zhu TN, Pan JQ, Shen ZJ, Zhao YQ, Shen T. Gene polymorphisms of renin-angiotensin system and coronary artery thrombosis disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2004;12(5):674-9.
19. Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, Berdeli A, Akin M. Renin-angiotensin system gene polymorphisms and the premature coronary heart disease. J Renin Angiotensin Aldosterone Syst 2005;6(1):38-42. (Pubitemid 40796847)
20. Andrikopoulos GK, Richter DJ, Needham EW, Tzeis SE, Zairis MN, Gialafos EJ, Vogiatzi PG, Papasteriadis EG, Kardaras FG, Foussas SG, Gialafos JE, Stefanadis CI, Toutouzas PK, Mattu RK, GEMIG Study Investigators. The paradoxical association of common polymorphisms of the renin-angiotensin system genes with risk of myocardial infarction. Eur J Cardiovasc Prev Rehabil 2004;11(6):477-83. (Pubitemid 40096849)
21. Lao O, Dupanloup I, Barbujani G, Bertranpetit J, Calafell F. The Mediterranean paradox for susceptibility factors in coronary heart disease extends to genetics. Ann Hum Genet 2008;72(pt1):48-56.
22. Rijn MJ, Boss MJ, Isaacs A, Yazdanpanah M, Arias-Vazquez A, Stricker BH, Klungel OH, Oostra BA, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM, van Duijn CM. Polymorphisms of the renin- angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. J Neurol Neurosurg Psychiatry 2007;78(10):1083-7.
23. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006;22:1928-9. (Pubitemid 44283043)
24. Gonzalez JR, Armengol L, Sole X, Guinó E, Mercader JM, Estivill X, Moreno V. SNPassoc: An R package to perform whole genome association studies. Bioinformatics 2007;23(5):644-5. (Pubitemid 46522604)
25. Akasaka H, Katsuya T, Saitoh S, Sugimto K, Fu Y, Takagi S, Ohnishi H, Rakugi H, Ura N, Shimamoto K, Ogihara T. Effects of angiotensin II type 1 receptor gene polymorphism on insulin resistance in Japanese general population: the Tanno-Sobetsu study. Hypertens Res 2006;29:961-7. (Pubitemid 46206582)
26. Abdollahi MR, Gaunt TR, Synddall HE, Cooper C, Phillips DI, Ye S, Day IN. Angiotensin II type 1 receptor gene polymorphism: anthropometric and metabolic traits. J Med Genet 2005;42:396-401. (Pubitemid 40685680)
27. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series No. 894. Geneva: WHO; 2000.
28. Leander K, Wiman B, Hallqvist J, Andersson T, Ahlbom A, de Faire U. Primary risk factors of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology program (SHEEP). Eur J Cardiovasc Prev Rehabil 2007;14(4):532-7. (Pubitemid 47229735)
29. Takeno M, Yasuda S, Otsuka Y, Morii I, Kawamura A, Yano K, Miyazaki S. Impact of metabolic syndrome on the long term survival of patients with acute myocardial infarction: potential association with C-reactive protein. Circ J 2008;72(3):415-9. (Pubitemid 351600635)